Assessment of biological activity of the caffeine‐derived Pt (II) and Pd (II) complexes-Reference-Cited by-同舟云学术

Assessment of biological activity of the caffeine‐derived Pt (II) and Pd (II) complexes

Published:2021-12-06 Issue:2 Volume:36 Page:
ISSN:0268-2605
Container-title:Applied Organometallic Chemistry
language:en
Short-container-title:Applied Organom Chemis

Author:

Jovanović‐Stević Snežana¹^ORCID,Ćoćić Dušan²^ORCID,Puchta Ralph³⁴⁵^ORCID,Bogojeski Jovana²^ORCID,Jurišević Milena⁶^ORCID,Gajović Nevena⁷^ORCID,Jakovljević Slobodan⁸^ORCID,Arsenijević Nebojša⁷^ORCID,Jovanović Ivan⁷^ORCID,Petrović Biljana²^ORCID

Affiliation:

1. Institute for Information Technologies Kragujevac, Department of Science University of Kragujevac Kragujevac Serbia

2. Faculty of Science University of Kragujevac Kragujevac Serbia

3. Inorganic Chemistry, Department of Chemistry and Pharmacy University of Erlangen‐Nürnberg Erlangen Germany

4. Computer Chemistry Center, Department of Chemistry and Pharmacy University of Erlangen‐Nürnberg Erlangen Germany

5. ZISC (Zentralinstitut für Scientific Computing) Universität Erlangen‐Nürnberg Erlangen Germany

6. Faculty of Medical Sciences, Department of Clinical Pharmacy University of Kragujevac Kragujevac Serbia

7. Faculty of Medical Sciences, Center for Molecular Medicine and Stem Cell Research University of Kragujevac Kragujevac Serbia

8. Clinical Center of Kragujevac University of Kragujevac Kragujevac Serbia

Funder

Ministry of Education

Publisher

Wiley

Subject

Inorganic Chemistry,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/aoc.6532

Reference48 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Bioinorganic Medicinal Chemistry

3. Mechanistic insight on the chemistry of potential Pt antitumor agents as revealed by collaborative research performed in Kragujevac and Erlangen

4. Bis-pyrazolylpyridine Complexes of Some Transition Metal Ions: Structure-Activity Relationships and Biological Activity

5. Metal complexes in cancer therapy – an update from drug design perspective